Osteosarcoma in Dogs: The Most Common Bone Cancer and What to Expect
Osteosarcoma is the most frequently diagnosed primary bone tumour in dogs, accounting for roughly 85% of all skeletal malignancies in the species. It is an aggressive cancer that most commonly affects large and giant breeds, and understanding what it is, how it presents, and what treatment looks like can help owners navigate one of the most emotionally challenging diagnoses a pet can receive.
Which Dogs Are Most at Risk
Breed and body size are the strongest risk factors for osteosarcoma. Great Danes, Irish Wolfhounds, Saint Bernards, Rottweilers, Greyhounds, and German Shepherd Dogs are among the breeds most commonly affected. The sheer mechanical load placed on the long bones of large dogs is thought to contribute to abnormal cellular replication over time. Most affected dogs are middle-aged to older, typically between seven and ten years, though the condition can occur in younger animals, particularly giant breeds.
The appendicular skeleton — meaning the limbs — is involved in approximately 75% of cases. The distal radius (just above the wrist), the proximal humerus (upper front leg), and the distal femur (just above the knee) are the most frequently affected sites. Axial osteosarcoma, affecting the skull, ribs, vertebrae, or pelvis, accounts for the remainder and can present quite differently.
Recognising the Signs
The earliest symptom owners typically notice is lameness, which may appear intermittent at first before becoming constant and severe. Swelling around the affected bone develops as the tumour grows and begins destroying normal bone architecture. The pain associated with osteosarcoma is significant — the cancer creates microscopic fractures within the bone and triggers inflammatory responses that cause considerable discomfort even before visible swelling appears.
Some dogs will be reluctant to bear weight on the affected limb, may cry out when the area is touched, or may show general signs of pain such as restlessness, reduced appetite, and behavioural changes. In advanced cases, pathological fractures — where the bone breaks through normal activity because it has been so weakened — can occur.
How Osteosarcoma Is Diagnosed
Radiographs of the affected limb are the first diagnostic step and typically reveal a characteristic appearance that experienced vets can identify with reasonable confidence. The bone may show a "sunburst" pattern of new bone formation, irregular lysis (destruction), and soft tissue involvement. However, definitive diagnosis requires biopsy or, in many cases, is confirmed following amputation of the limb.
Staging investigations are equally important. Because osteosarcoma metastasises rapidly — most commonly to the lungs — chest radiographs or CT scanning, along with abdominal ultrasound and bone scintigraphy, help establish whether the cancer has already spread. Tragically, studies suggest that at the time of diagnosis, approximately 90% of dogs already have micrometastatic disease, even when imaging appears clear.
Treatment Options and What They Involve
The standard of care for appendicular osteosarcoma combines surgical removal with chemotherapy. Amputation of the affected limb remains the primary surgical option and, for most dogs, dramatically and rapidly resolves pain. Dogs adapt remarkably well to three-legged life, particularly those that are not significantly overweight or suffering from concurrent orthopaedic issues in other limbs.
Limb-sparing surgery is available at specialist centres for select patients, typically involving removal of the affected bone segment and replacement with a bone graft or metal implant. It is technically demanding and carries risks including infection, implant failure, and local tumour recurrence, but it is an option worth exploring for dogs unsuitable for amputation.
Chemotherapy following surgery — most commonly carboplatin or doxorubicin — is aimed at targeting micrometastatic disease and extending survival. Without chemotherapy after amputation, median survival is approximately four months. With adjuvant chemotherapy, median survival increases to around ten to twelve months, with roughly 20 to 25% of dogs surviving to two years.
Palliative Management for Dogs Who Cannot Undergo Surgery
Not every dog is a surgical candidate, whether due to age, concurrent health problems, financial constraints, or owner preference. Palliative care focuses on pain management to maintain quality of life for as long as reasonably possible. This typically involves non-steroidal anti-inflammatory drugs, gabapentin, tramadol, and in some cases palliative radiation therapy, which can significantly reduce bone pain even without curing the disease.
Bisphosphonate drugs such as pamidronate, given by intravenous infusion, help reduce bone resorption and can decrease pain while potentially slowing localised bone destruction. Regular reassessment of pain levels is essential, and owners are encouraged to use quality-of-life scoring tools to guide decisions about when palliative care is no longer sufficient.
Emerging Research and Future Directions
The prognosis for osteosarcoma remains poor despite decades of research, which has driven interest in novel therapies. Immunotherapy approaches, including tumour vaccines and checkpoint inhibitors, are under active investigation in veterinary oncology. Interestingly, because canine osteosarcoma shares many genetic and clinical similarities with the human form of the disease (osteosarcoma also affects adolescent humans), dogs have become valuable natural models for translational cancer research, creating a genuinely reciprocal benefit between veterinary and human medicine.
Toceranib phosphate (Palladia), a tyrosine kinase inhibitor, has shown some activity against osteosarcoma in combination protocols, and clinical trials at veterinary schools continue to offer enrolled patients access to cutting-edge treatments that are not yet commercially available.
Supporting a Dog Through Diagnosis
Receiving an osteosarcoma diagnosis for a dog is devastating. The disease moves quickly, and the decisions owners must make — often under emotional duress — are genuinely difficult. Seeking consultation at a veterinary oncology centre is strongly advisable, as specialists can provide the most current treatment protocols, realistic prognosis information, and emotional support resources. Speaking with owners who have been through the same experience, via reputable support communities, can also provide comfort and practical insight during a profoundly hard time.